Year: 2021

Director Jean-Pierre Bizzari, MD, is a Doctor of Medicine, graduate of the Nice medical school and a specialist in oncology. He served as Executive Vice-President, Group Head, and Clinical Oncology Development (US, Europe, and Asia/Japan) at Celgene from 2008 to 2015. Prior to joining Celgene, he served as Vice President for Clinical Development Oncology at… Continue reading Dr. Jean-Pierre BIZZARI

Independent Director Antoine Béret was Chief Executive Officer (CEO) of Genoscience Pharma SAS and Chairman of Axenis. He graduated from École Nationale des Ponts et Chaussées and Ecole Polytechnique. Antoine Béret co-founded several companies specializing in biomedicine, including Trophos where he served as CEO until 2008 and Immunotech that he directed until 1996 when Immunotech… Continue reading Antoine BÉRET

Director, Chairman of the Strategy Committee Jean-Luc Bélingard was Chairman and Chief Executive Officer of bioMérieux S.A from 2010 to 2017. He graduated from the Ecole des Hautes Etudes Commerciales (HEC) of Paris (1971) and holds a Master of Business Administration (MBA) from Cornell University, US (1974). Since then, he has held management positions at… Continue reading Jean-Luc BÉLINGARD

Director Philippe Archinard, Ph.D. has been Executive Vice-President, Technological Innovation and Scientific Partnerships at Institut Mérieux since 2021. He was Chairman and Chief Executive Officer of Transgene from 2010 to 2020; and CEO from 2004 to 2020. Previously he was CEO of Innogenetics from 2000 to 2010. From 1985 to 2000, he held various positions… Continue reading Philippe ARCHINARD

VP, Human Resources Director Christelle SCHWOERER was appointed Director of Human Resources and joined the Executive Committee in April 2024. She joined Transgene’s Human Resources department in December 2013 as a Human Resources Assistant, after initial experience in construction and industry. Her various roles at Transgene have enabled her to develop generalist skills in human… Continue reading Gaëlle STADTLER

VP, General Counsel & Corporate Secretary John Felitti joined Transgene in 2016 as General Counsel & Corporate Secretary. Before joining Transgene, he was Associate Vice President, Corporate Law, Finance & Securities Law at Sanofi and previously held other positions in the Sanofi and the Aventis legal departments. From 1996 to 2003, he was an associate… Continue reading John FELITTI

VP, Chief Business Officer James Wentworth, PhD, joined Transgene in 2024. Dr. Wentworth is responsible for developing, leading, and implementing Transgene’s business, corporate development and partnering strategies. He has over 15 years of experience working in the pharma and biotech industry.  James was Director, Business Development and Strategy at Adaptimmune, a NASDAQ-listed biotechnology company focused… Continue reading James WENTWORTH, PhD

VP, Chief Financial Officer (CFO) Lucie is appointed on March 27 as Chief Financial Officer, responsible for all aspects of the Company’s financial strategy, management and operations to ensure efficient delivery of Transgene’s innovative immunotherapy pipeline. Since 2016, Lucie has served as Director Corporate Communications and Investor Relations, reporting to the CEO and joins the… Continue reading Lucie Larguier

  VP, Chief Quality Officer & Qualified Pharmacist Christophe Ancel joined Transgene in 2008, first as Head of Quality Assurance and then as Vice President, Operational Quality. Prior to that, he was a consultant for several international pharmaceutical groups. From 2001 to 2005, he was Head of Quality, Assistant Pharmacist and Interim Responsible Pharmacist for… Continue reading Christophe ANCEL